Source: PaxForex Premium Analytics Portal, Fundamental Insight Pharmaceutical giant Pfizer has been at the forefront of the industry, developing drugs to treat COVID since the pandemic began. Unfortunately, the world continues to struggle with different strains of the virus, most recently with the Omicron variant, but Pfizer's products are still in high demand, which will likely boost its results in 2022. It's been about a year since the first COVID vaccine became available in the U.S., and a race has begun to ramp up production...
Source: PaxForex Premium Analytics Portal, Fundamental Insight UK Nationwide House Prices for December increased 1.0% monthly and 10.4% annualized. Forex traders can compare this to UK Nationwide House Prices for November, which increased 0.9% monthly and 10.0% annualized. Dutch Business Confidence for December was reported at 10.2. Forex traders can compare this to Dutch Business Confidence for November, reported at 12.7. The Preliminary Spanish CPI for December increased 1.3% monthly and 6.7% annualized. Forex traders can compare this...
Source: PaxForex Premium Analytics Portal, Fundamental Insight The relaunch of Walt Disney's theme parks and growth from three streaming services (Disney+, Hulu, ESPN+) were not enough to boost the stock in 2021. The stock price is now down 14.5% from a year ago, behind the 27% return of the S&P 500 Index. The Parks segment has recovered well, with revenues nearly doubling year-over-year in its fiscal fourth quarter. However, slowing growth from Disney's main streaming service, Disney+, caused the stock to fall toward the end...
Source: PaxForex Premium Analytics Portal, Technical Insight Most traders remain away from their desks until the second Monday in January. It is a seasonal pattern over the Christmas holidays and New Year, resulting in thin trading volume. It often pushes equity markets higher, also known as a Santa Claus, or Santa, rally. Volatility may increase as portfolio managers adjust portfolios before the end of the year to compute performance and bonus payments. They usually rush into the closed positions in the new year, creating a positive start...
Source: PaxForex Premium Analytics Portal, Fundamental Insight For much of the previous decade, the stock of diversified healthcare behemoth Johnson & Johnson has consistently delivered market returns (if you count dividends as part of total return on equity). Investors flocked to this company because of its solid balance sheet, its status as a dividend aristocrat, and its unique ability to consistently bring new blockbuster pharmaceutical products to market in a timely manner. Since the beginning of this decade, however, J&J stock...
